文献速递肝病

深部腹部超声换能器(DAX)提高肥胖患者剪切波弹性成像评估肝纤维化的成功率和诊断准确性——一项前瞻性活检对照研究

The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity-A prospective biopsy-controlled study.
PubMed 文献 · Aliment Pharmacol Ther · 2024-05-01

该前瞻性活检对照研究纳入129例以肥胖为主、MASLD高患病率患者,比较VCTE及标准5C1与DAX换能器上pSWE和2D-SWE的肝硬度检测。DAX上pSWE在意向诊断分析中显著优于VCTE-LSM,各技术对≥F3和F4诊断准确性良好至优秀,对≥F2较差。

要点

  • VCTE-LSM失败或不可靠者占20.9%。
  • 各LSM技术对显著纤维化(≥F2)AUC为0.54-0.63,准确性差。
  • 各LSM技术对进展期纤维化(≥F3)AUC为0.87-0.99,对肝硬化(F4)AUC为0.86-1.00。

核心结论

  • pSWE和2D-SWE可无创识别肥胖MASLD患者的进展期纤维化和肝硬化。
  • DAX换能器用于ARFI-LSM可避免肥胖人群技术失败,在评估有纤维化风险的肥胖MASLD人群纤维化方面优于VCTE-LSM。

研究设计与样本

  • 前瞻性活检对照研究,纳入129例有配对LSM和肝活检的患者,以肥胖为主且MASLD高患病率。
  • 中位年龄44.0岁,女性82例(63.6%),中位BMI 43.2 kg/m2。
  • 组织学纤维化分期:F0 55例(42.6%)、F1 14例(10.9%)、F2 50例(38.8%)、F3 2例(1.6%)、F4 8例(6.2%)。
  • LSM采用VCTE以及标准5C1和DAX换能器上的pSWE与2D-SWE测量。

主要发现

  • VCTE-LSM失败13例,不可靠(IQR/中位数≤30%且≥7.1 kPa)14例,合计占20.9%。
  • 可靠VCTE-LSM与pSWE及2D-SWE的Pearson相关系数均>0.78。
  • 各LSM技术对显著纤维化(≥F2)AUC为0.54-0.63,对进展期纤维化(≥F3)AUC为0.87-0.99,对肝硬化(F4)AUC为0.86-1.00。
  • 意向诊断分析中,DAX上pSWE显著优于VCTE-LSM。

关键数值与推荐

  • VCTE-LSM不可靠定义为IQR/中位数≤30%且≥7.1 kPa。
  • 诊断准确性:≥F2的AUC 0.54-0.63;≥F3的AUC 0.87-0.99;F4的AUC 0.86-1.00。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity impacts the diagnostic accuracy of shear wave elastography (SWE). A deep abdominal ultrasound transducer (DAX) capable of point (pSWE) and two-dimensional (2D)-SWE has recently been introduced to address this issue. METHODS: We performed a prospective study in a cohort of mostly patients with obesity undergoing liver biopsy with a high prevalence of metabolic dysfunction-associate steatotic liver disease (MASLD). Liver stiffness measurement (LSM) was measured using vibration-controlled transient elastography (VCTE), as well as pSWE and 2D SWE on the standard (5C1) and the DAX transducers. RESULTS: We included 129 patients with paired LSM and liver biopsy: median age 44.0 years, 82 (63.6%) women, median BMI: 43.2 kg/m2. Histologic fibrosis stages: F0: N = 55 (42.6%), F1: N = 14 (10.9%), F2: N = 50 (38.8%), F3: N = 2 (1.6%), F4: N = 8 (6.2%). VCTE-LSM failed (N = 13) or were unreliable (IQR/median ≤30% in ≥7.1 kPa, N = 14) in 20.9% of patients. The Pearson correlation of reliable VCTE-LSM with both pSWE and 2D SWE was strong (all >0.78). The diagnostic accuracy for all LSM techniques was poor for significant fibrosis (≥F2, AUC: 0.54-0.63); however, it was good to excellent for advanced fibrosis (≥F3, AUC: 0.87-0.99) and cirrhosis (F4, AUC: 0.86-1.00). In intention-to-diagnose analysis, pSWE on DAX was significantly superior to VCTE-LSM. CONCLUSIONS: pSWE- and 2D-SWE enable the non-invasive identification of advanced fibrosis and cirrhosis in patients with obese MASLD. The use of the DAX transducer for acoustic radiation force imaging (ARFI)-LSM avoids technical failures in an obese population and subsequently offers advantages over VCTE-LSM for the evaluation of fibrosis in an obese MASLD population at risk for fibrosis.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Bauer DJM, Nixdorf L, Dominik N, et al. The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity-A prospective biopsy-controlled study. Aliment Pharmacol Ther. 2024. PMID: 38693718. doi:10.1111/apt.18019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。